title: Epigallocatechin gallate attenuates L-DOPA-induced apoptosis in rat PC12 cells.
abstract: In this study, the protective effects of EGCG on L-3,4-dihydroxyphenylalanine (L-DOPA)-induced oxidative cell death in catecholaminergic PC12 cells, the in vitro model of Parkinson's disease, were investigated. Treatment with L-DOPA at concentrations higher than 150 µM caused cytotoxicity in PC12 cells, as determined using the 3-(4,5-dimetylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and flow cytometry detection. The apoptotic ratio was similar in cells treated with 100 µM EGCG plus 150 µM L-DOPA (5.02%) and the control (0.96%) (P > 0.05), and was lower than that of cells treated with L-DOPA only (32.24%, P < 0.05). The generation level of ROS (% of control) in cells treated with EGCG plus L-DOPA was lower than that in cells treated with L-DOPA only (123.90% vs 272.32%, P < 0.05). The optical density in production of TBARS in cells treated with L-DOPA only was higher than that in the control (0.27 ± 0.05 vs 0.08 ± 0.04, P < 0.05), and in cells treated with EGCG only (0.14 ± 0.02, P < 0.05), and EGCG plus L-DOPA (0.13 ± 0.02, P < 0.05). The intracellular level of GSH in cells treated with EGCG plus L-DOPA was higher than that in cells treated with L-DOPA only (233.25 ± 16.44 vs 119.23 ± 10.25, P < 0.05). These results suggest that EGCG protects against L-DOPA-induced oxidative apoptosis in PC12 cells, and might be a potent neuroprotective agent.
authors: Department of Food and Nutrition, College of Natural Science, Chosun University, 301, Pilmun-daero, Dong-gu, Gwangju 501-759, Korea.
authors: Myung-Yul
authors: MY
authors: Lee
authors: Eun Joo
authors: EJ
authors: Choi
authors: Myung-Koo
authors: MK
authors: Lee
authors: Jae-Joon
authors: JJ
authors: Lee
keywords: Epillocatechin gallate; L-DOPA; PC12 cells; apoptosis; oxidative stress
references: Methods Enzymol. 1990;186:421-31
references: 2233309
references: J Neurochem. 1997 Jan;68(1):426-9
references: 8978755
references: Arch Biochem Biophys. 2002 Jan 15;397(2):424-9
references: 11795903
references: J Neurochem. 2001 Sep;78(5):1073-82
references: 11553681
references: J Neurochem. 1995 Nov;65(5):2016-21
references: 7595485
references: J Neurochem. 1995 Feb;64(2):825-32
references: 7830076
references: Biochim Biophys Acta. 1999 Mar 14;1427(1):13-23
references: 10082983
references: Clin Neuropharmacol. 1990 Oct;13(5):448-58
references: 2272024
references: Free Radic Res. 1998 Oct;29(4):359-65
references: 9860051
references: Brain Res. 1996 Dec 16;743(1-2):278-83
references: 9017256
references: J Nutr Biochem. 2002 Feb;13(2):103-111
references: 11834226
references: J Neurochem. 1989 Feb;52(2):381-9
references: 2911023
references: Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8
references: 1065897
references: J Clin Invest. 1995 Jun;95(6):2458-64
references: 7769091
references: Toxicol Appl Pharmacol. 2005 Sep 15;207(3):212-20
references: 16129114
references: FASEB J. 2003 May;17(8):952-4
references: 12670874
references: Free Radic Biol Med. 1990;8(6):507-14
references: 2163349
references: Biochem Pharmacol. 2003 Nov 1;66(9):1787-95
references: 14563489
references: Neuroreport. 1995 Jul 31;6(11):1480-4
references: 7579129
references: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references: 6606682
references: Lancet. 1991 Jun 1;337(8753):1321-4
references: 1674304
references: Life Sci. 2007 Mar 20;80(15):1355-63
references: 17240404
references: J Neurochem. 2005 Aug;94(4):1005-14
references: 16000163
references: Brain Res Mol Brain Res. 2003 Oct 21;118(1-2):72-81
references: 14559356
references: J Neurochem. 1999 Sep;73(3):1155-63
references: 10461907
references: Biochim Biophys Acta. 1996 Dec 13;1304(3):210-22
references: 8982267
references: Mol Neurobiol. 1994 Aug-Dec;9(1-3):135-42
references: 7888089
references: Arch Biochem Biophys. 2002 Jan 1;397(1):84-90
references: 11747313
references: Cancer Res. 1997 Oct 1;57(19):4414-9
references: 9331105
references: Ann N Y Acad Sci. 2008 Sep;1138:358-65
references: 18837911
references: J Food Sci. 2008 Mar;73(2):H28-32
references: 18298733
references: Biochim Biophys Acta. 1995 May 24;1271(1):265-74
references: 7599219
references: Anal Biochem. 1980 Jul 15;106(1):207-12
references: 7416462
references: Biochem Mol Biol Int. 1995 Apr;35(5):995-1008
references: 7549942
references: Neuroreport. 1996 Mar 22;7(4):921-3
references: 8724674
references: Toxicology. 2004 Jan 15;195(1):53-60
references: 14698567
references: Phytomedicine. 2002 Apr;9(3):232-8
references: 12046864
references: Neurosci Lett. 1999 Apr 2;264(1-3):1-4
references: 10319999
references: J Neurol. 2003 Oct;250 Suppl 3:III15-24
references: 14579120
references: Biochem Pharmacol. 2002 Jan 1;63(1):21-9
references: 11754870
references: J Agric Food Chem. 2001 Dec;49(12):6033-8
references: 11743804
references: J Neurochem. 2000 Jun;74(6):2268-77
references: 10820186